share_log

冠昊生物(300238.SZ):开展的本维莫德乳膏特应性皮炎三期临床尚在有序推进中

Guanhao biotech (300238.SZ): the Phase III clinical trial of Benvimode cream for atopic dermatitis is still progressing in an orderly manner.

Gelonghui Finance ·  Jul 12 03:49

On July 12th, Gelonhui reported that an investor asked Guanhao Biotech (300238.SZ) on the interactive platform for investors, 'The new indication of pemodermatitis for Bemovate has been in Phase III clinical stage for a long time, please elaborate on the current progress.' The company replied that the Phase III clinical trial of Bemovate cream for special pemodermatitis is still progressing orderly. Please pay attention to the company's announcement for follow-up progress.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment